Grifols, S.A. GRFS

Company Overview

Grifols, S.A. is a global healthcare company headquartered in Spain, specializing in plasma-derived medicines, transfusion medicine, and diagnostic solutions. The company operates primarily within the biopharmaceuticals and medical diagnostics industries, with a strong focus on therapies derived from human plasma. Grifols’ core revenue drivers are plasma collection, plasma fractionation, and the commercialization of immunoglobulins, albumin, coagulation factors, and diagnostic reagents used by hospitals and clinical laboratories.

Founded in 1940 in Barcelona as a family-owned laboratory, Grifols evolved from a regional diagnostics supplier into a vertically integrated global plasma leader. A key strategic advantage is its control over the entire plasma value chain, from donor collection through manufacturing and distribution. This integrated model supports supply security, regulatory compliance, and cost efficiency, differentiating Grifols from competitors that rely more heavily on third-party plasma sourcing.